Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1979 Nov 17;121(10):1353–1358.

Platelet transfusions.

J G Kelton, M A Blajchman
PMCID: PMC1704511  PMID: 391376

Abstract

Platelets play a pivotal role in hemostasis by forming the initial hemostatic plug and augmenting the formation of the more permanent fibrin thrombus. Thrombocytopenia may lead to bleeding, which can be treated with therapeutic platelet transfusions or prevented with prophylactic transfusions. While many advances have been made in platelet transfusion technology, problems remain. These include the short storage life of liquid-stored platelets and the frequent development of alloantibodies (the refractory state) in patients receiving a number of transfusions. Significant progress, however, is being made in both areas.

Full text

PDF
1353

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson N., Eisenberg P. D., Aster R. H. Post-transfusion purpura: immunologic aspects and therapy. N Engl J Med. 1974 Nov 28;291(22):1163–1166. doi: 10.1056/NEJM197411282912205. [DOI] [PubMed] [Google Scholar]
  2. Aster R. H. Effect of anticoagulant and ABO incompatibility on recovery of transfused human platelets. Blood. 1965 Dec;26(6):732–743. [PubMed] [Google Scholar]
  3. Becker G. A., Tuccelli M., Kunicki T., Chalos M. K., Aster R. H. Studies of platelet concentrates stored at 22 C nad 4 C. Transfusion. 1973 Mar;13(2):61–68. doi: 10.1111/j.1537-2995.1973.tb05442.x. [DOI] [PubMed] [Google Scholar]
  4. Brand A., van Leeuwen A., Eernisse J. G., van Rood J. J. Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests. Blood. 1978 May;51(5):781–788. [PubMed] [Google Scholar]
  5. Bucher U., de Weck A., Spengler H., Tschopp L., Kummer H. Platelet transfusions: shortened survival of HL-A-identical platelets and failure of in vitro detection of anti-platelet antibodies after multiple transfusions. Vox Sang. 1973;25(2):187–192. doi: 10.1111/j.1423-0410.1973.tb04829.x. [DOI] [PubMed] [Google Scholar]
  6. Buchholz D. H., Young V. M., Friedman N. R., Reilly J. A., Mardiney M. R., Jr Bacterial proliferation in platelet products stored at room temperature. Transfusion-induced Enterobacter sepsis. N Engl J Med. 1971 Aug 19;285(8):429–433. doi: 10.1056/NEJM197108192850803. [DOI] [PubMed] [Google Scholar]
  7. Buchholz D. H., Young V. M., Friedman N. R., Reilly J. A., Mardiney M. R., Jr Detection and quantitation of bacteria in platelet products stored at ambient temperature. Transfusion. 1973 Sep-Oct;13(5):268–275. doi: 10.1111/j.1537-2995.1973.tb05488.x. [DOI] [PubMed] [Google Scholar]
  8. Copley A. L. Editorial: Bleeding time, other in vivo hemostasis tests and the arrest of hemorrhage. Thromb Res. 1974 Jan;4(1):1–23. doi: 10.1016/0049-3848(74)90200-x. [DOI] [PubMed] [Google Scholar]
  9. Dayian G., Rowe A. W. Cryopreservation of human platelets for transfusion: a glycerol-glucose, moderate rate cooling procedure. Cryobiology. 1976 Feb;13(1):1–8. doi: 10.1016/0011-2240(76)90153-x. [DOI] [PubMed] [Google Scholar]
  10. Duquesnoy R. J., Filip D. J., Aster R. H. Influence of HLA-A2 on the effectiveness of platelet transfusions in alloimmunized thrombocytopenic patients. Blood. 1977 Sep;50(3):407–412. [PubMed] [Google Scholar]
  11. Duquesnoy R. J., Filip D. J., Rodey G. E., Rimm A. A., Aster R. H. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol. 1977;2(3):219–226. doi: 10.1002/ajh.2830020303. [DOI] [PubMed] [Google Scholar]
  12. Filip D. J., Aster R. H. Relative hemostatic effectiveness of human platelets stored at 4 degrees and 22 degrees C. J Lab Clin Med. 1978 Apr;91(4):618–624. [PubMed] [Google Scholar]
  13. Fratantoni J. C. Status report on methods of platelet preservation. Transfusion. 1976 Jan-Feb;16(1):1–1. doi: 10.1046/j.1537-2995.1976.16176130828.x. [DOI] [PubMed] [Google Scholar]
  14. GAYDOS L. A., FREIREICH E. J., MANTEL N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med. 1962 May 3;266:905–909. doi: 10.1056/NEJM196205032661802. [DOI] [PubMed] [Google Scholar]
  15. GUREVITCH J., NELKEN D. ABO groups in blood platelets. Nature. 1954 Feb 20;173(4399):356–356. doi: 10.1038/173356a0. [DOI] [PubMed] [Google Scholar]
  16. Gardner F. H. Use of platelet transfusions. Br J Haematol. 1974 Aug;27(4):537–542. doi: 10.1111/j.1365-2141.1974.tb06618.x. [DOI] [PubMed] [Google Scholar]
  17. Garfield M. D., Ershler W. B., Maki D. G. Malaria transmission by platelet concentrate transfusion. JAMA. 1978 Nov 17;240(21):2285–2286. [PubMed] [Google Scholar]
  18. Gerrard J. M., Stoddard S. F., Shapiro R. S., Coccia P. F., Ramsay N. K., Nesbit M. E., Rao G. H., Krivit W., White J. G. Platelet storage pool deficiency and prostaglandin synthesis in chronic granulocytic leukaemia. Br J Haematol. 1978 Dec;40(4):597–607. doi: 10.1111/j.1365-2141.1978.tb05836.x. [DOI] [PubMed] [Google Scholar]
  19. Giddings J. C., Shearn S. A., Bloom A. L. Platelet-associated coagulation factors: immunological detection and the effect of calcium. Br J Haematol. 1978 Aug;39(4):569–577. doi: 10.1111/j.1365-2141.1978.tb03627.x. [DOI] [PubMed] [Google Scholar]
  20. Grumet F. C., Yankee R. A. Long-term platelet support of patients with aplastic anemia. Effect of splenectomy and steroid therapy. Ann Intern Med. 1970 Jul;73(1):1–7. doi: 10.7326/0003-4819-73-1-1. [DOI] [PubMed] [Google Scholar]
  21. HIRSCH E. O., GARDNER F. H. The transfusion of human blood platelets with a note on the transfusion of granulocytes. J Lab Clin Med. 1952 Apr;39(4):556–569. [PubMed] [Google Scholar]
  22. Harker L. A., Slichter S. J. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med. 1972 Jul 27;287(4):155–159. doi: 10.1056/NEJM197207272870401. [DOI] [PubMed] [Google Scholar]
  23. Henry R. L. Platelet function. Semin Thromb Hemost. 1977 Fall;4(2):93–122. doi: 10.1055/s-0028-1087130. [DOI] [PubMed] [Google Scholar]
  24. Herzig R. H., Herzig G. P., Bull M. I., Decter J. A., Lohrmann H. P., Stout F. G., Yankee R. A., Graw R. G., Jr Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentrates. Blood. 1975 Nov;46(5):743–750. [PubMed] [Google Scholar]
  25. Herzig R. H., Poplack D. G., Yankee R. A. Prolonged granulocytopenia from incompatible platelet transfusions. N Engl J Med. 1974 May 30;290(22):1220–1223. doi: 10.1056/NEJM197405302902203. [DOI] [PubMed] [Google Scholar]
  26. Higby D. J., Cohen E., Holland J. F., Sinks L. The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study. Transfusion. 1974 Sep-Oct;14(5):440–446. doi: 10.1111/j.1537-2995.1974.tb04558.x. [DOI] [PubMed] [Google Scholar]
  27. Hirschman R. J., Shulman N. R. The use of platelet serotonin release as a sensitive method for detecting anti-platelet antibodies and a plasma anti-platelet factor in patients with idiopathic thrombocytopenic purpura. Br J Haematol. 1973 Jun;24(6):793–802. doi: 10.1111/j.1365-2141.1973.tb01707.x. [DOI] [PubMed] [Google Scholar]
  28. Howard J. E., Perkins H. A. The natural history of alloimmunization to platelets. Transfusion. 1978 Jul-Aug;18(4):496–503. doi: 10.1046/j.1537-2995.1978.18478251250.x. [DOI] [PubMed] [Google Scholar]
  29. Karpatkin S., Strick N., Karpatkin M. B., Siskind G. W. Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders. Am J Med. 1972 Jun;52(6):776–785. doi: 10.1016/0002-9343(72)90084-8. [DOI] [PubMed] [Google Scholar]
  30. Kelton J. G., Neame P. B., Bishop J., Ali M., Gauldie J., Hirsh J. The direct assay for platelet-associated IgG (PAIgG): lack of association between antibody level and platelet size. Blood. 1979 Jan;53(1):73–80. [PubMed] [Google Scholar]
  31. Kelton J. G., Neame P. B., Gauldie J., Hirsh J. Elevated platelet-associated IgG in the thrombocytopenia of septicemia. N Engl J Med. 1979 Apr 5;300(14):760–764. doi: 10.1056/NEJM197904053001404. [DOI] [PubMed] [Google Scholar]
  32. Kitchens C. S., Weiss L. Ultrastructural changes of endothelium associated with thrombocytopenia. Blood. 1975 Oct;46(4):567–578. [PubMed] [Google Scholar]
  33. Lohrmann H. P., Bull M. I., Decter J. A., Yankee R. A., Graw R. G., Jr Platelet transfusions from HL-A compatible unrelated donors to alloimmunized patients. Ann Intern Med. 1974 Jan;80(1):9–14. doi: 10.7326/0003-4819-80-1-9. [DOI] [PubMed] [Google Scholar]
  34. McNamara J. J., Anderson B. S., Hayashi T. Stored blood platelets and microaggregate formation. Surg Gynecol Obstet. 1978 Oct;147(4):507–512. [PubMed] [Google Scholar]
  35. Mittal K. K., Ruder E. A., Green D. Matching of histocompatibility (HL-A) antigens for platelet transfusion. Blood. 1976 Jan;47(1):31–41. [PubMed] [Google Scholar]
  36. Moss R. A., Castro O. Platgelet transfusion for quinidine-induced thrombocytopenia. N Engl J Med. 1973 Mar 8;288(10):522–523. doi: 10.1056/NEJM197303082881013. [DOI] [PubMed] [Google Scholar]
  37. Mueller-Eckhardt C., Mersch-Baumert K. The problem of platelet autoantibodies. I. Evaluation of the platelet factor 3 availability test for their detection. Vox Sang. 1977 Oct;33(4):221–233. doi: 10.1111/j.1423-0410.1977.tb04467.x. [DOI] [PubMed] [Google Scholar]
  38. Murphy S. Platelet transfusion. Prog Hemost Thromb. 1976;3:289–310. [PubMed] [Google Scholar]
  39. Murphy S., Sayar S. N., Abdou N. L., Gardner F. H. Platelet preservation by freezing. Use of dimethylsulfoxide as cryoprotective agent. Transfusion. 1974 Mar-Apr;14(2):139–144. doi: 10.1111/j.1537-2995.1974.tb04505.x. [DOI] [PubMed] [Google Scholar]
  40. Nagasawa T., Kim B. K., Baldini M. G. Temporary suppression of circulating antiplatelet alloantibodies by the massive infusion of fresh, stored, or lyophilized platelets. Transfusion. 1978 Jul-Aug;18(4):429–435. doi: 10.1046/j.1537-2995.1978.18478251236.x. [DOI] [PubMed] [Google Scholar]
  41. PEARSON H. A., SHULMAN N. R., MARDER V. J., CONE T. E., Jr ISOIMMUNE NEONATAL THROMBOCYTOPENIC PURPURA. CLINICAL AND THERAPEUTIC CONSIDERATIONS. Blood. 1964 Feb;23:154–177. [PubMed] [Google Scholar]
  42. Roy A. J., Jaffe N., Djerassi I. Prophylactic platelet transfusions in children with acute leukemia: a dose response study. Transfusion. 1973 Sep-Oct;13(5):283–290. doi: 10.1111/j.1537-2995.1973.tb05490.x. [DOI] [PubMed] [Google Scholar]
  43. SHULMAN N. R., MARDER V. J., HILLER M. C., COLLIER E. M. PLATELET AND LEUKOCYTE ISOANTIGENS AND THEIR ANTIBODIES: SEROLOGIC PHYSIOLOGIC AND CLINICAL STUDIES. Prog Hematol. 1964;4:222–304. [PubMed] [Google Scholar]
  44. Schiffer C. A., Aisner J., Wiernik P. H. Frozen autologous platelet transfusion for patients with leukemia. N Engl J Med. 1978 Jul 6;299(1):7–12. doi: 10.1056/NEJM197807062990102. [DOI] [PubMed] [Google Scholar]
  45. Schiffer C. A., Lichtenfeld J. L., Wiernik P. H., Mardiney M. R., Jr, Joseph J. M. Antibody response in patients with acute nonlymphocytic leukemia. Cancer. 1976 May;37(5):2177–2182. doi: 10.1002/1097-0142(197605)37:5<2177::aid-cncr2820370504>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  46. Schiffer C. A. Some aspects of recent advances in the use of blood cell components. Br J Haematol. 1978 Jul;39(3):289–294. doi: 10.1111/j.1365-2141.1978.tb01100.x. [DOI] [PubMed] [Google Scholar]
  47. Seidenfeld A. M., Owen J., Glynn M. F. Post-transfusion purpura cured by steroid therapy in a man. Can Med Assoc J. 1978 May 20;118(10):1285–1286. [PMC free article] [PubMed] [Google Scholar]
  48. Slichter S. J., Harker L. A. Preparation and storage of platelet concentrates. Transfusion. 1976 Jan-Feb;16(1):8–12. doi: 10.1046/j.1537-2995.1976.16176130842.x. [DOI] [PubMed] [Google Scholar]
  49. Vogin E. E., Carson S., Cannon G., Linegar C. R., Rubin L. F. Chronic toxicity of DMSO in primates. Toxicol Appl Pharmacol. 1970 May;16(3):606–612. doi: 10.1016/0041-008x(70)90065-7. [DOI] [PubMed] [Google Scholar]
  50. Walsh P. N., Camp E., Dende D. Different requirements for intrinsic factor-Xa forming activity and platelet factor 3 activity and their relationship to platelet aggregation and secretion. Br J Haematol. 1978 Oct;40(2):311–331. doi: 10.1111/j.1365-2141.1978.tb03667.x. [DOI] [PubMed] [Google Scholar]
  51. Wieckowicz M. Single donor platelet transfusions: scientific, legal, and ethical considerations. Transfusion. 1976 May-Jun;16(3):193–199. doi: 10.1046/j.1537-2995.1976.16376225488.x. [DOI] [PubMed] [Google Scholar]
  52. Wood D. C., Weber F. S., Palmquist M. A. Continued studies in the toxicology of dimethyl sulfoxide (DMSO). J Pharmacol Exp Ther. 1971 Jun;177(3):520–527. [PubMed] [Google Scholar]
  53. Wu K. K., Hoak J. C., Koepke J. A., Thompson J. S. Selection of compatible platelet donors: a prospective evaluation of three cross-matching techniques. Transfusion. 1977 Nov-Dec;17(6):638–643. doi: 10.1046/j.1537-2995.1977.17678075665.x. [DOI] [PubMed] [Google Scholar]
  54. Wu K. K., Hoak J. C., Thompson J. S., Koepke J. A. Use of platelet aggregometry in selection of compatible platelet donors. N Engl J Med. 1975 Jan 16;292(3):130–133. doi: 10.1056/NEJM197501162920303. [DOI] [PubMed] [Google Scholar]
  55. von dem Borne A. E., Verheugt F. W., Oosterhof F., von Riesz E., de la Rivière A. B., Engelfriet C. P. A simple immunofluorescence test for the detection of platelet antibodies. Br J Haematol. 1978 Jun;39(2):195–207. doi: 10.1111/j.1365-2141.1978.tb01089.x. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES